something has to give.....the share price is absolutely ridiculous, page-2

Jackie Fairley said that an expected milestone in late 2018 or early 2019 was going to be the completion of DEP-Docetaxel Phase 2 trial. This would be one full year before the world had heard of Covid. So any Covid excuse by the 3 amigos in charge of this company is lame and complete and utter rubbish and spin.

Whichever way Jackie Fairley tries to obfuscate, spin, reinvent the wheel or reassemble history, the facts are we are heading toward 4 years since she said the DEP-Docetaxel trial was expected to be complete.

This can only mean one thing. It’s just that many shareholders just don’t want to acknowledge it. And these same shareholders don’t seem to want to hold Jackie Fairley to account for the things that are going wrong and for treating shareholders like mugs and mushrooms.

DYOR